Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Analysis of Survival Data: Challenges and Algorithm-Based Model Selection.

Sarkar K, Chowdhury R, Dasgupta A.

J Clin Diagn Res. 2017 Jun;11(6):LC14-LC20. doi: 10.7860/JCDR/2017/21903.10019. Epub 2017 Jun 1. Review.

2.

Cancer in Korean patients with end-stage renal disease: A 7-year follow-up.

Yoo KD, Lee JP, Lee SM, Park JY, Lee H, Kim DK, Kang SW, Yang CW, Kim YL, Lim CS, Joo KW, Kim YS.

PLoS One. 2017 Jul 10;12(7):e0178649. doi: 10.1371/journal.pone.0178649. eCollection 2017.

3.

Temporal trend in dementia incidence since 2002 and projections for prevalence in England and Wales to 2040: modelling study.

Ahmadi-Abhari S, Guzman-Castillo M, Bandosz P, Shipley MJ, Muniz-Terrera G, Singh-Manoux A, Kivimäki M, Steptoe A, Capewell S, O'Flaherty M, Brunner EJ.

BMJ. 2017 Jul 5;358:j2856. doi: 10.1136/bmj.j2856.

4.

Clinical and Economic Burden of Peristomal Skin Complications in Patients With Recent Ostomies.

Taneja C, Netsch D, Rolstad BS, Inglese G, Lamerato L, Oster G.

J Wound Ostomy Continence Nurs. 2017 Jul/Aug;44(4):350-357. doi: 10.1097/WON.0000000000000339.

5.

Actual over 10-year survival after liver resection for patients with intrahepatic cholangiocarcinoma.

Si A, Li J, Xiang H, Zhang S, Bai S, Yang P, Zhang X, Xia Y, Wang K, Yan Z, Lau WY, Shi L, Shen F.

Oncotarget. 2017 Jul 4;8(27):44521-44532. doi: 10.18632/oncotarget.17815.

6.

Serum inflammatory markers and colorectal cancer risk and survival.

Ghuman S, Van Hemelrijck M, Garmo H, Holmberg L, Malmström H, Lambe M, Hammar N, Walldius G, Jungner I, Wulaningsih W.

Br J Cancer. 2017 May 9;116(10):1358-1365. doi: 10.1038/bjc.2017.96. Epub 2017 Apr 4.

PMID:
28376082
7.

Age at First Identification of Autism Spectrum Disorder: An Analysis of Two US Surveys.

Sheldrick RC, Maye MP, Carter AS.

J Am Acad Child Adolesc Psychiatry. 2017 Apr;56(4):313-320. doi: 10.1016/j.jaac.2017.01.012. Epub 2017 Feb 3.

PMID:
28335875
8.

Survival analysis in the presence of competing risks.

Zhang Z.

Ann Transl Med. 2017 Feb;5(3):47. doi: 10.21037/atm.2016.08.62.

9.

Statin use and all-cause and cancer mortality: BioBank Japan cohort.

Yokomichi H, Nagai A, Hirata M, Tamakoshi A, Kiyohara Y, Kamatani Y, Muto K, Ninomiya T, Matsuda K, Kubo M, Nakamura Y; BioBank Japan Cooperative Hospital Group, Yamagata Z.

J Epidemiol. 2017 Mar;27(3S):S84-S91. doi: 10.1016/j.je.2016.12.011. Epub 2017 Feb 11.

10.

Influence of Left Ventricular Stroke Volume on Incident Heart Failure in a Population With Preserved Ejection Fraction (from the Strong Heart Study).

De Marco M, Gerdts E, Mancusi C, Roman MJ, Lønnebakken MT, Lee ET, Howard BV, Devereux RB, de Simone G.

Am J Cardiol. 2017 Apr 1;119(7):1047-1052. doi: 10.1016/j.amjcard.2016.12.011. Epub 2017 Jan 5.

PMID:
28159195
11.

Comparative cardiovascular risks of dipeptidyl peptidase 4 inhibitors with other second- and third-line antidiabetic drugs in patients with type 2 diabetes.

Ou HT, Chang KC, Li CY, Wu JS.

Br J Clin Pharmacol. 2017 Jul;83(7):1556-1570. doi: 10.1111/bcp.13241. Epub 2017 Feb 27.

PMID:
28109184
12.

Association of CKD-MBD Markers with All-Cause Mortality in Prevalent Hemodialysis Patients: A Cohort Study in Beijing.

Li D, Zhang L, Zuo L, Jin CG, Li WG, Chen JB.

PLoS One. 2017 Jan 3;12(1):e0168537. doi: 10.1371/journal.pone.0168537. eCollection 2017.

13.

Health-Related Quality of Life Impacts Mortality but Not Progression to End-Stage Renal Disease in Pre-Dialysis Chronic Kidney Disease: A Prospective Observational Study.

Jesky MD, Dutton M, Dasgupta I, Yadav P, Ng KP, Fenton A, Kyte D, Ferro CJ, Calvert M, Cockwell P, Stringer SJ.

PLoS One. 2016 Nov 10;11(11):e0165675. doi: 10.1371/journal.pone.0165675. eCollection 2016.

14.

The Association Between Rate and Severity of Exacerbations in Chronic Obstructive Pulmonary Disease: An Application of a Joint Frailty-Logistic Model.

Sadatsafavi M, Sin DD, Zafari Z, Criner G, Connett JE, Lazarus S, Han M, Martinez F, Albert R.

Am J Epidemiol. 2016 Nov 1;184(9):681-689. Epub 2016 Oct 13.

15.

Timing of HIV Seroreversion Among HIV-Exposed, Breastfed Infants in Malawi: Type of HIV Rapid Test Matters.

Smith ER, Hudgens M, Sheahan AD, Miller WC, Wheeler S, Nelson JA, Dube Q, Van Rie A.

Matern Child Health J. 2017 Feb;21(2):248-252. doi: 10.1007/s10995-016-2152-4.

16.

Persistence to 5-year hormonal breast cancer therapy: a French national population-based study.

Bosco-Lévy P, Jové J, Robinson P, Moore N, Fourrier-Réglat A, Bezin J.

Br J Cancer. 2016 Oct 11;115(8):912-919. doi: 10.1038/bjc.2016.276. Epub 2016 Sep 6.

17.

A case-matched study of stereotactic radiosurgery for patients with brain metastases: comparing treatment results for those with versus without neurological symptoms.

Koiso T, Yamamoto M, Kawabe T, Watanabe S, Sato Y, Higuchi Y, Yamamoto T, Matsumura A, Kasuya H, Barfod BE.

J Neurooncol. 2016 Dec;130(3):581-590. Epub 2016 Sep 3.

18.

The Effect of a Multi-Level Intervention on the Initiation of Antiretroviral Therapy (ART) among HIV-Infected Men Who Inject Drugs and Were Diagnosed Late in Thai Nguyen, Vietnam.

Zelaya CE, Le Minh N, Lau B, Latkin CA, Viet Ha T, Minh Quan V, Mo TT, Sripaipan T, Davis WW, Celentano DD, Frangakis C, Go VF.

PLoS One. 2016 Aug 31;11(8):e0161718. doi: 10.1371/journal.pone.0161718. eCollection 2016.

19.

An external validation of models to predict the onset of chronic kidney disease using population-based electronic health records from Salford, UK.

Fraccaro P, van der Veer S, Brown B, Prosperi M, O'Donoghue D, Collins GS, Buchan I, Peek N.

BMC Med. 2016 Jul 12;14:104. doi: 10.1186/s12916-016-0650-2.

20.

Specificity of Genetic Biomarker Studies in Cancer Research: A Systematic Review.

Green G, Carmona R, Zakeri K, Lee CH, Borgan S, Marhoon Z, Sharabi A, Mell LK.

PLoS One. 2016 Jul 6;11(7):e0156489. doi: 10.1371/journal.pone.0156489. eCollection 2016. Review.

Supplemental Content

Support Center